Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage ...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...
New blood test could improve survival rates of deadly cancer - Pancreatic cancer is the fifth most common cause of cancer ...
A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.
Money Talks News on MSN
A simple blood test claims to detect 50 cancers but isn't FDA-approved yet
A new blood test analyzes DNA fragments to screen for 50 types of cancer simultaneously. The $949 Galleri test detected ...
Most people assume diabetes is easy to diagnose. You take a blood test, get a number, and that’s it. But in real life, it’s ...
Hone Health reports that chronic inflammation is a key factor in heart disease risk often overlooked in standard health ...
A new blood test has been developed that could improve survival rates for pancreatic cancer, a disease frequently diagnosed ...
10hon MSN
A 'window to the brain': Chip tracks glioblastoma treatment response using tumor vesicles in blood
Technology created at the University of Queensland could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions. Dr. Richard Lobb and Dr. Zhen Zhang from ...
Grail has filed for Food and Drug Administration approval of its multi-cancer early detection test, the company said Thursday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results